G1 Therapeutics

• NCT06027268

  Collaborator, Phase 2, Active, not recruiting, 36 people, 7 Sept 2023

• NCT05112536

  Phase 2, Completed, 24 people, 9 Nov 2021

• NCT05071703

  Collaborator, Phase 4, Completed, 30 people, 8 Oct 2021

• NCT04902885

  Collaborator, Phase 3, Completed, 95 people, 26 May 2021

• NCT04887831

  Phase 2, Terminated, 92 people, 14 May 2021

• NCT04799249

  Phase 3, Completed, 194 people, 16 Mar 2021

• NCT03455270

  Phase 1, Completed, 107 people, 6 Mar 2018

• NCT03041311

  Phase 2, Completed, 107 people, 2 Feb 2017

• NCT02983071

  Phase 1/2, Status unknown, 102 people, 6 Dec 2016

• NCT02978716

  Phase 2, Terminated, 102 people, 1 Dec 2016

• NCT02499770

  Phase 1/2, Completed, 122 people, 16 Jul 2015

• Age-diet interactions significantly influence intratumoral gene expression, gut microbiome signature and tumor microenvironment in colorectal cancer

  Consulting or advice, Fees or honoraria, Board or leadership role, 25 Oct 2025

Sources: pubmed.ncbi.nlm.nih.gov